title: Challenges for the new Cancer Drugs Fund.
authors.affiliation: Department of Primary Care and Public Health Sciences, King's College London, London WC2R 2LS, UK.
authors.forename: Peter
authors.initials: P
authors.lastname: Littlejohns
authors.affiliation: Department of Political Sciences, University College London, London, UK.
authors.forename: Albert
authors.initials: A
authors.lastname: Weale
authors.affiliation: Department of Primary Care and Public Health Sciences, King's College London, London WC2R 2LS, UK.
authors.forename: Katharina
authors.initials: K
authors.lastname: Kieslich
authors.affiliation: Department of Philosophy, University College London, London, UK.
authors.forename: James
authors.initials: J
authors.lastname: Wilson
authors.affiliation: Department of Philosophy, University College London, London, UK.
authors.forename: Benedict
authors.initials: B
authors.lastname: Rumbold
authors.affiliation: Catherine Max Consulting, London, UK.
authors.forename: Catherine
authors.initials: C
authors.lastname: Max
authors.affiliation: Department of Social Science, Health & Medicine, King's College London, London WC2R 2LS, UK. Electronic address: annette.rid@kcl.ac.uk.
authors.forename: Annette
authors.initials: A
authors.lastname: Rid
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D005376:Financial Management; D006801:Humans; D013222:State Medicine; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents